Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactionsMabel A Cejas, William A Kinney, Cailin Chen, et al.Bioorganic & Medicinal Chemistry|February 24, 2006
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agentEdward C Lawson, Rosemary J Santulli, Alexey B Dyatkin, et al.European Journal of Pharmacology|July 5, 2008
Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonistJoseph W Gunnet, Pamela Wines, Min Xiang, et al.European Journal of Pharmacology|May 24, 2008
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitorLeah Aluisio, Brian Lord, Ann J Barbier, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding SiteBruce E Maryanoff, John C O'Neill, David F McComsey, et al.Clinical and Experimental Pharmacology & Physiology|April 20, 2006
Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonistJoseph W Gunnet, Jay M Matthews, Bruce E Maryanoff, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonistsJay M Matthews, Michael N Greco, Leonard R Hecker, et al.Journal of Medicinal Chemistry|September 8, 2009
Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunitsEdward C Lawson, Diane K Luci, Shyamali Ghosh, et al.Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: synthesis, SAR, and in vivo assessmentDiane K Luci, Shyamali Ghosh, Charles E Smith, et al.Journal of Medicinal Chemistry|January 28, 2010
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motifTianbao Lu, Thomas Markotan, Shelley K Ballentine, et al.Pageof 8